Career Conversations 51: AI, EQ and You

Dagmar Albers is a transformation strategist and award‑winning consultant with more than 25 years’ experience in Pharma and FMCG, supporting organisations unlock clarity, confidence and capability in a fast‑changing world. She specialises in translating customer and employee insights into smarter strategies, stronger positioning and sustainable business impact, combining data, adaptive roadmapping and bold creative thinking to turn complexity into clarity.

As Co‑Founder of Innovationin, a 2025 and 2026 finalist for New Business of the Year, Dagmar partners with organisations ready for a workplace revolution to thrive in a world shaped by AI, hybrid work and shifting career paths. Her work blends behavioural science, leadership development, equity and customer insight to strengthen the people side of AI transformation, ensuring change is measurable, meaningful and lasting.
Previously, Dagmar designed and delivered Pfizer UK’s award‑winning Gender and Ethnicity Pay Gap strategy and is co‑author of Innovationin'sThe Visibility Advantage (2025), a practical toolkit for building confidence, influence and career agility.

Dagmar serves as Vice President, EMEA for the Healthcare Businesswomen’s Association (HBA), shaping the healthcare ecosystem to accelerate equity and develop leaders for life. She is a recipient of the HBA ACE Award, recognised for leading Pfizer UK’s breakthrough strategy that halved the organisation’s gender pay gap in just four years — from 15.9% to 6.6%.

Elizabeth Turner has spent her career working across sales leadership, marketing and market access functions at biopharmaceutical companies of varying therapeutic focus and development stages. Liz currently serves as Vice President, Global Market Access at Mirum. Prior to Mirum, she served in similar roles at Galera Therapeutics and Arena Pharmaceuticals. Before her transition to Market Access, Liz served in both marketing and sales roles of increasing leadership responsibility for 10 years at Amgen and five years at Pfizer. Liz holds an MBA from the University of Central Florida and a BA in mass communications from the University of South Florida.

Dr. Tiffany St. Bernard is an accomplished entrepreneur and medical AI researcher. She earned her PhD in Biomedical Engineering from Cornell University and completed her postdoctoral work at Cornell Tech, where she developed AI-driven visual diagnostic solutions for dermatology. As the Founder and CEO of SOCAi Labs (pronounced so-kai), a computational dermatology lab, she is at the forefront of objective AI-powered precision health solutions. Her work is supported by notable institutions such as the National Science Foundation (NSF), National Institutes of Health (NIH), and US Health & Human Services (HHS). At SOCAi Labs, Dr. Tiff is dedicated to leveraging AI to revolutionize health, wellness, and beauty diagnostics, ensuring personalized care is accessible to all. SOCAi’s mission improves quality of care and innovation in medical practices, research, and at-home care.